Literature DB >> 19763599

Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma.

Kenya Yuki1, Dogru Murat, Itaru Kimura, Yuichiro Ohtake, Kazuo Tsubota.   

Abstract

BACKGROUND: Vitamin A, B(9), C, E, and uric acid are well-known antioxidants and may prevent age-related eye disorders. The aim of the present study was to investigate the levels of antioxidant vitamins, A, B(9), C, E, and antioxidative substance, uric acid in the serum of Japanese patients with normal-tension glaucoma and compare the results with normal controls.
METHODS: All subjects with suspicion of primary open-angle glaucoma who came to the glaucoma subspeciality clinic of Keio University Hospital were enrolled in this study. Sixty patients (28 males, 32 females; mean age +/- standard deviation: 59.9 +/- 9.8 years) with newly diagnosed primary open-angle glaucoma patients were consecutively enrolled in this study. After the diagnosis of primary open-angle glaucoma, the patients underwent 24-h IOP measurements. Forty-seven newly diagnosed consecutive normal-tension glaucoma patients (18 males, 29 females; mean age +/- standard deviation: 59.5 +/- 10.2 years) were enrolled in this study. The control subjects were recruited from subjects who came to the clinic for annual refractive check-up. The 44 consecutive control subjects of the current study, (16 males, 28 females; 62.7 +/- 14.8 years) did not have any ocular diseases. The serum levels of vitamins A, B(9), C, E, and uric acid were measured. The values were compared between the normal-tension glaucoma and control groups by the Mann-Whitney U test.
RESULTS: Serum levels of vitamin C were significantly lower in normal-tension glaucoma patients than in normal healthy controls (P = 0.04; normal-tension glaucoma; 4.6 +/- 4.0 microg/ml control; 6.3 +/- 3.9 microg/ml). Uric acid level was significantly higher in normal-tension glaucoma patients than in controls (P = 0.01; normal-tension glaucoma; 5.8 +/- 1.5 mg/dl control; 4.9 +/- 1.4 mg/dl). No statistically significant difference was seen in vitamin A (P = 0.41; normal-tension glaucoma; 82.1 +/- 26.7 microg/dl control; 77.1 +/- 30.1 microg/dl), B(9) (P = 0.37; normal-tension glaucoma; 8.7 +/- 4.3 ng/ml control; 8.0 +/- 3.1 ng/ml)and E (P = 0.83; normal-tension glaucoma; 1.5 +/- 0.6 control; 1.5 +/- 0.6) levels between normal-tension glaucoma and control groups.
CONCLUSION: Normal-tension glaucoma patients had lower serum levels of vitamin C and increased levels of uric acid. These observations may pave the way for possible alternative treatment for normal-tension glaucoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763599     DOI: 10.1007/s00417-009-1183-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  45 in total

1.  Transfer of ascorbic acid and related compounds across the blood-aqueous barrier.

Authors:  V E KINSEY
Journal:  Am J Ophthalmol       Date:  1947-10       Impact factor: 5.258

2.  Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma.

Authors:  Doina Gherghel; Helen Rosemary Griffiths; Emma Jane Hilton; Ian Andrew Cunliffe; Sarah Louise Hosking
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-03       Impact factor: 4.799

3.  The pressure lowering effect of ascorbic acid in ocular hypertension.

Authors:  E Linnér
Journal:  Acta Ophthalmol (Copenh)       Date:  1969

4.  Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma.

Authors:  Sergio Claudio Saccà; Antonio Pascotto; Paola Camicione; Paolo Capris; Alberto Izzotti
Journal:  Arch Ophthalmol       Date:  2005-04

5.  Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.

Authors:  Luciano Quaranta; Sabina Bettelli; Maurizio G Uva; Francesco Semeraro; Raffaele Turano; Enrico Gandolfo
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

6.  Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma.

Authors:  Y Munemasa; J H Ahn; J M K Kwong; J Caprioli; N Piri
Journal:  Gene Ther       Date:  2008-08-14       Impact factor: 5.250

7.  Inhibition of oxidative degradation of hyaluronic acid by uric acid.

Authors:  K M Liu; D Swann; P Lee; K W Lam
Journal:  Curr Eye Res       Date:  1984-08       Impact factor: 2.424

Review 8.  Scientific basis for medical therapy of cataracts by antioxidants.

Authors:  S D Varma
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

Review 9.  Normal-tension glaucoma: is it different from primary open-angle glaucoma?

Authors:  M Bruce Shields
Journal:  Curr Opin Ophthalmol       Date:  2008-03       Impact factor: 3.761

10.  Intravenous glycerol-vitamin C (sodium salt) as osmotic agents to reduce intraocular pressure.

Authors:  M Virno; M G Bucci; J Pecori-Giraldi; G Cantore
Journal:  Am J Ophthalmol       Date:  1966-11       Impact factor: 5.258

View more
  26 in total

Review 1.  Genetic Variation in Human Vitamin C Transporter Genes in Common Complex Diseases.

Authors:  Mandana Amir Shaghaghi; Olena Kloss; Peter Eck
Journal:  Adv Nutr       Date:  2016-03-15       Impact factor: 8.701

Review 2.  Dietary factors and the risk of glaucoma: a review.

Authors:  Igor I Bussel; Ahmad A Aref
Journal:  Ther Adv Chronic Dis       Date:  2014-07       Impact factor: 5.091

Review 3.  Antioxidants and vision health: facts and fiction.

Authors:  Ashok K Grover; Sue E Samson
Journal:  Mol Cell Biochem       Date:  2013-12-06       Impact factor: 3.396

4.  Association of serum retinol concentration with normal-tension glaucoma.

Authors:  Ruiqi Pang; Shuo Feng; Kai Cao; Yunxiao Sun; Yiqin Guo; Dandan Ma; Chi Pui Pang; Xiangyi Liu; Jingyu Qian; Yuan Xie; Yan Shi; Hailong He; Jun Peng; Congyan Chen; Jing Cui; Siloka A Labisi; Yue Zhang; Yingdi Fu; Jiaying Li; Yue Wan; Chen Xin; Hanruo Liu; Qing Zhang; Robert N Weinreb; Huaizhou Wang; Ningli Wang
Journal:  Eye (Lond)       Date:  2021-08-12       Impact factor: 4.456

5.  Could the AREDS formula benefit patients with glaucoma?

Authors:  Abhishek Sethi; Thasarat Sutabutr Vajaranant
Journal:  Eye (Lond)       Date:  2022-01-29       Impact factor: 4.456

6.  Renin-angiotensin system involvement in the oxidative stress-induced neurodegeneration of cultured retinal ganglion cells.

Authors:  Yoko Ozawa; Kenya Yuki; Reiko Yamagishi; Kazuo Tsubota; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2012-10-24       Impact factor: 2.447

7.  Ascorbic acid modulation of iron homeostasis and lysosomal function in trabecular meshwork cells.

Authors:  Ping Xu; Yizhi Lin; Kristine Porter; Paloma B Liton
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-19       Impact factor: 2.671

8.  Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States.

Authors:  S Y Wang; K Singh; S C Lin
Journal:  Eye (Lond)       Date:  2013-02-22       Impact factor: 3.775

9.  Gout and open-angle glaucoma risk in a veteran population.

Authors:  Kristin S Biggerstaff; Donna L White; Benjamin J Frankfort; Peter Richardson; Silvia Orengo-Nania; Jose Garcia; Elizabeth Y Chiao; Jennifer R Kramer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-17       Impact factor: 3.117

10.  Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population.

Authors:  Vicente Zanon-Moreno; Lucia Ciancotti-Olivares; Jeronimo Asencio; Pedro Sanz; Carolina Ortega-Azorin; Maria D Pinazo-Duran; Dolores Corella
Journal:  Mol Vis       Date:  2011-11-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.